Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated:  1/18/2016
mi
from
Rochester, NY
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated: 1/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated:  1/20/2016
mi
from
Boston, MA
Telemedicine Interventions for Obstructive Sleep Apnea (OSA)
An RCT of Telemedicine Interventions for OSA
Status: Enrolling
Updated: 1/20/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Status: Enrolling
Updated:  1/20/2016
mi
from
Durham, NC
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
Status: Enrolling
Updated: 1/20/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated:  1/22/2016
mi
from
Birmingham, AL
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Sleep D/O Center of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated:  1/22/2016
mi
from
Little Rock, AR
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Arkansas Center for Sleep Medicine
mi
from
Little Rock, AR
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated:  1/22/2016
mi
from
Atlanta, GA
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated:  1/22/2016
mi
from
St. Louis, MO
Sleep Disordered Breathing and Chronic Pain
BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)
Status: Enrolling
Updated: 1/22/2016
Clayton Sleep Institute
mi
from
St. Louis, MO
Click here to add this to my saved trials
Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)
An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides
Status: Enrolling
Updated:  1/25/2016
mi
from
Syracuse, NY
Adjunctive Brief Behavioral Treatment of Insomnia (BBTI) for Sleep Intervention (SI)
An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides
Status: Enrolling
Updated: 1/25/2016
Syracuse VA Medical Center, Syracuse, NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
Behavioral Insomnia Therapy With Fibromyalgia
Status: Enrolling
Updated:  1/28/2016
mi
from
Durham, NC
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
Behavioral Insomnia Therapy With Fibromyalgia
Status: Enrolling
Updated: 1/28/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Helping Young Children Sleep
Helping Young Children Sleep
Status: Enrolling
Updated:  1/28/2016
mi
from
Columbus, OH
Helping Young Children Sleep
Helping Young Children Sleep
Status: Enrolling
Updated: 1/28/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Development of an Insomnia Treatment for Depressed Adolescents
Development of an Insomnia Treatment for Depressed Adolescents
Status: Enrolling
Updated:  1/28/2016
mi
from
Ann Arbor, MI
Development of an Insomnia Treatment for Depressed Adolescents
Development of an Insomnia Treatment for Depressed Adolescents
Status: Enrolling
Updated: 1/28/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Birmingham, AL
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Irvine, CA
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
University of California - Irvine Medical Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
San Diego, CA
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Rady Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Gainesville, FL
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Kansas City, KA
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Boston, MA
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Greenwood, SC
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Greenwood Genetic Center
mi
from
Greenwood, SC
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Nashville, TN
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated:  2/1/2016
mi
from
Houston, TX
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
Status: Enrolling
Updated: 2/1/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated:  2/2/2016
mi
from
Bridgewater, NJ
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Sanofi-Aventis Administrative Office
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated:  2/2/2016
mi
from
Buenos Aires,
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study
Status: Enrolling
Updated: 2/2/2016
Sanofi-Aventis Administrative Office
mi
from
Buenos Aires,
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated:  2/5/2016
mi
from
Bridgewater, NJ
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Sanofi-Aventis Administrative Office
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated:  2/5/2016
mi
from
Wien,
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Status: Enrolling
Updated: 2/5/2016
Sanofi-Aventis Administrative Office
mi
from
Wien,
Click here to add this to my saved trials
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Status: Enrolling
Updated:  2/8/2016
mi
from
St. Paul, MN
Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children
A Phase II, Randomized, Placebo-controlled, Double Blind, Cross-over, Study of the Effects of Gabapentin on Chronic Irritability in Neurologically Impaired Children
Status: Enrolling
Updated: 2/8/2016
Gillette Children's Specialty Healthcare
mi
from
St. Paul, MN
Click here to add this to my saved trials
Sleep Length and Circadian Regulation in Humans
Sleep Length and Circadian Regulation in Humans
Status: Enrolling
Updated:  2/9/2016
mi
from
Chicago, IL
Sleep Length and Circadian Regulation in Humans
Sleep Length and Circadian Regulation in Humans
Status: Enrolling
Updated: 2/9/2016
Biological Rhythms Research Laboratory, RUMC
mi
from
Chicago, IL
Click here to add this to my saved trials
CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients
Testing an Accessible Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention in Newly Diagnosed Cancer Patients
Status: Enrolling
Updated:  2/9/2016
mi
from
Richmond, VA
CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients
Testing an Accessible Cognitive Behavioral Therapy for Insomnia (CBT-I) Intervention in Newly Diagnosed Cancer Patients
Status: Enrolling
Updated: 2/9/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Hot Springs, AR
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Central Arkansas Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Los Angeles, CA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Pacific Sleep Medicine Services, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
San Diego, CA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Pacific Sleep Medicine Services, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
San Diego, CA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
California Clinical Trials Medical Group, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Brandon, FL
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Miami, FL
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Naples, FL
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
OmniTrials
mi
from
Naples, FL
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Pembroke Pines, FL
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Broward Research Group & Sleep-Wake Disorders Center of South Florida
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Atlanta, GA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Atlanta, GA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Sleep Disorders Center of Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Overland Park, KA
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Crestview Hills, KY
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Community Research
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Troy, MI
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Clinical Neurophysiology Services, P.C.
mi
from
Troy, MI
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Chesterfield, MO
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Sleep Disorders & Research Center
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Las Vegas, NV
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Clinical Research Center of Nevada, LLC
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Durham, NC
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Cincinnati, OH
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Tri-State Sleep Disorders Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Cleveland, OH
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Cleveland Clinic Health Systems
mi
from
Cleveland, OH
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Oklahoma City, OK
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Lynn Health Sciences Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Columbia, SC
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Sleep Disorders Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated:  2/11/2016
mi
from
Dallas, TX
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Status: Enrolling
Updated: 2/11/2016
Sleep Medicine Associates P.A.
mi
from
Dallas, TX
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated:  2/12/2016
mi
from
Birmingham, AL
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated:  2/12/2016
mi
from
Chandler, AZ
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials